Accès libre

Validation of the Slovenian version of the low anterior resection syndrome score for rectal cancer patients after surgery

Jan Grosek
Jan Grosek
, 
Jurij Aleš Košir
Jurij Aleš Košir
, 
Jerica Novak
Jerica Novak
, 
Mirko Omejc
Mirko Omejc
, 
Aleš Tomažič
Aleš Tomažič
 et 
Gregor Norčič
Gregor Norčič
   | 01 oct. 2019
Slovenian Journal of Public Health's Cover Image
À propos de cet article
Article précédent
Article suivant
Citez
Article Category: Original scientific article
Publié en ligne: 01 oct. 2019
Pages: 148 - 154
Reçu: 12 oct. 2018
Accepté: 03 juil. 2019
DOI: https://doi.org/10.2478/sjph-2019-0019
Mots clés
© 2019 National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Figure 1

Study flowchart. A total of 100 patients were included in the analysis. Of those, 51 were included in the test-retest analysis.
Study flowchart. A total of 100 patients were included in the analysis. Of those, 51 were included in the test-retest analysis.

Figure 2

Bland-Altman plot illustrating the difference between the numerical LARSS values at the first and second test (solid line denotes mean difference, dashed lines denote limits of agreement).
Bland-Altman plot illustrating the difference between the numerical LARSS values at the first and second test (solid line denotes mean difference, dashed lines denote limits of agreement).

Figure 3

Box plot showing the relationship between the LARSS and the QoL group.
Box plot showing the relationship between the LARSS and the QoL group.

Figure 4

The LARSS in clinical subgroups: radiotherapy, type of surgery and age.
The LARSS in clinical subgroups: radiotherapy, type of surgery and age.

Agreement between responses at the first and the second LARS test for each question of the LARSS.

Perfect Moderate No
Q1 78.4 (66.7–90.1) 15.7 (5.4–26.0) 5.9 (0–11.6)
Q2 72.5 (59.9–85.2) 25.5 (13.1–37.9) 2.0 (0–5.9)
Q3 78.4 (66.7–90.1) 19.6 (8.3–30.9) 2.0 (0–5.9)
Q4 76.5 (64.4–88.5) 17.6 (6.8-28.5) 5.9 (0-12.6)
Q5 78.4 (66.7–90.1) 19.6 (8.3–30.9) 2.0 (0–5.9)

Fit between the LARSS group and the QoL group.

Fit n% (95% CI)
No 10.0 (4.0-16.0)
Moderate 24.0 (14.5-32.5)
Perfect 66.0 (56.5-75.4)

The Slovenian version of Low Anterior Resection Syndrome Score (LARSS) (11).

1. Se vam kdaj zgodi, da ne morete zadržati uhajanje vetrov?
- Ne, nikoli 0
- Da, manj kot enkrat na teden 4
- Da, vsaj enkrat na teden 7
2. Se vam kdaj zgodi, da vam po nesreči uide nekaj tekočega blata?
- Ne, nikoli 0
- Da, manj kot enkrat na teden 3
- Da, vsaj enkrat na teden 3
3. Kako pogosto odvajate blato?
- Več kot 7-krat na dan (na 24 ur) 4
- Od 4- do 7-krat na dan (na 24 ur) 2
- Od 1- do 3-krat na dan (na 24 ur) 0
- Manj kot enkrat na dan (na 24 ur) 5
4. Se vam kdaj zgodi, da morate ponovno na blato v eni uri po zadnjem odvajanju blata?
- Ne, nikoli 0
- Da, manj kot enkrat na teden - Da, vsaj enkrat na teden 9 11
5. Ali kdaj občutite tako hudo siljenje na blato, da morate steči na stranišče?
- Ne, nikoli 0
- Da, manj kot enkrat na teden 11
- Da, vsaj enkrat na teden 16

Fit between the QoL category and the LARSS category.

Impact of bowel function on QoL No LARS (0-20 points) Minor LARS (21-29 points) Major LARS (30-42 points)
No 3 (3%) 2 (2%) 0 (0%)
Minor 8 (8%) 8 (8%) 3 (3%)
Some/major 10 (10%) 11 (11%) 55 (55%)

Patient characteristics.

N=100
Males, n (%) 69 (69)
Age in years at time of survey, mean (SD) 73.5 (10.6)
Age in years at time of operation mean (SD) 63.4 (10.5)
Tumour stage
T0-T2, n (%) 52 (52)
T3-T4, n (%) 48 (48)
Years since operation, mean (SD) 9.7 (1.4)
Type of surgery
TME, n (%) 69 (69)
PME, n (%) 31 (31)
Tumour level in cm, mean (SD) 9.4 (3.3)
Radiotherapy, n (%) 57 (57)
Chemotherapy, n (%) 69 (69)
eISSN:
1854-2476
Langue:
Anglais
Périodicité:
4 fois par an
Sujets de la revue:
Medicine, Clinical Medicine, Hygiene and Environmental Medicine
RSS Feed de la revue